Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment

References

• VenkateshaSHAstryBNanjundaiahSMYuHMoudgilKDSuppression of autoimmune arthritis by Celastrus-derived Celastrol through modulation of pro-inflammatory chemokinesBioorg Med Chem201220175229523422854193
   PubMedGoogle Scholar
• KimDYParkJWJeoungDRoJYCelastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma modelEur J Pharmacol20096121–39810519356734
   PubMed Web of Science ®Google Scholar
• NanjundaiahSMVenkateshaSHYuHTongLStainsJPMoudgilKDCelastrus and its bioactive celastrol protect against bone damage in autoimmune arthritis by modulating osteoimmune cross-talkJ Biol Chem201228726222162222622549786
   PubMedGoogle Scholar
• NeefDWJaegerAMThieleDJHeat shock transcription factor 1 as a therapeutic target in neurodegenerative diseasesNat Rev Drug Discov2011101293094422129991
   PubMedGoogle Scholar
• LuZJinYQiuLLaiYPanJCelastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutationCancer Lett2010290218219119819619
   PubMed Web of Science ®Google Scholar
• HuangYZhouYFanYZhouDCelastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expressionCancer Lett2008264110110618343027
   PubMed Web of Science ®Google Scholar
• JangSYJangSWKoJCelastrol inhibits the growth of estrogen positive human breast cancer cells through modulation of estrogen receptor alphaCancer Lett20113001576520934245
   PubMedGoogle Scholar
• KimYKangHJangSWKoJCelastrol inhibits breast cancer cell invasion via suppression of NF-kB-mediated matrix metalloproteinase-9 expressionCell Physiol Biochem201128217518421865725
   PubMedGoogle Scholar
• YangHChenDCuiQCYuanXDouQPCelastrol, a triterpene extracted from the chinese “Thunder of god vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude miceCancer Res20066694758476516651429
   PubMed Web of Science ®Google Scholar
• DaiYDesanoJTangWNatural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaBPLoS One2010512e1415321170316
   PubMed Web of Science ®Google Scholar
• QiXQinJMaNChouXWuZSolid self-microemulsifying dispersible tablets of celastrol: formulation development, characterization and bioavailability evaluationInt J Pharm20144721–2404724929011
   PubMed Web of Science ®Google Scholar
• LiuZMaLZhouGBThe main anticancer bullets of the Chinese medicinal herb, thunder god vineMolecules20111665283529721701438
   PubMed Web of Science ®Google Scholar
• SalminenALehtonenMPaimelaTKaarnirantaKCelastrol: molecular targets of Thunder God VineBiochem Biophys Res Commun2010394343944220226165
   PubMed Web of Science ®Google Scholar
• WolframJSuriKHuangYEvaluation of anticancer activity of celastrol liposomes in prostate cancer cellsJ Microencapsul201431550150724654943
   PubMed Web of Science ®Google Scholar
• SongJShiFZhangZFormulation and evaluation of celastrol-loaded liposomesMolecules20111697880789222143548
   PubMed Web of Science ®Google Scholar
• ChenYZhouLYuanLZhangZHLiuXWuQFormulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriersInt J Nanomedicine201273023303222787398
   PubMed Web of Science ®Google Scholar
• YuanLLiuCChenYZhangZZhouLQuDAntitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer modelInt J Nanomedicine201384339435024235831
   PubMed Web of Science ®Google Scholar
• SannaVSiddiquiIASechiMMukhtarHResveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatmentMol Pharm201310103871388123968375
   PubMedGoogle Scholar
• SannaVRoggioAMPosadinoAMNovel docetaxel-loaded nanoparticles based on Poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization and cytotoxicity studiesNanoscale Res Lett20116126021711774
   PubMedGoogle Scholar
• SannaVLubinuGMadauPPolymeric nanoparticles encapsulating white tea extract for nutraceutical applicationJ Agric Food Chem20156372026203225599125
   PubMed Web of Science ®Google Scholar
• AdhamiVMMalikAZamanNCombined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivoClin Cancer Res20071351611161917332308
   PubMed Web of Science ®Google Scholar
• SiddiquiIAMalikAAdhamiVMGreen tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasisOncogene200827142055206317998943
   PubMed Web of Science ®Google Scholar
• SiddiquiIABharaliDJNihalMExcellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivoNanomedicine20141081619162624965756
   PubMed Web of Science ®Google Scholar
• SiddiquiIAAdhamiVMBharaliDJIntroducing nanochemoprevention as a novel approach for cancer control: Proof of principle with green tea polyphenol epigallocatechin-3-gallateCancer Res20096951712171619223530
   PubMed Web of Science ®Google Scholar
• SiddiquiIAAdhamiVMAhmadNMukhtarHNanochemoprevention: sustained release of bioactive food components for cancer preventionNutr Cancer201062788389020924964
   PubMed Web of Science ®Google Scholar
• LeonarduzziGTestaGSotteroBGambaPPoliGDesign and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoidsCurr Med Chem2010171749519941477
   PubMed Web of Science ®Google Scholar
• SiddiquiIAMukhtarHNanochemoprevention by bioactive food components: a perspectivePharm Res20102761054106020221894
   PubMed Web of Science ®Google Scholar
• SannaVPintusGRoggioAMTargeted biocompatibile nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cellsJ Med Chem20115451321133221306166
   PubMed Web of Science ®Google Scholar
• SannaVSechiMNanoparticle therapeutics for prostate cancer treatmentNanomedicine20128Suppl 1S31S3622640911
   PubMed Web of Science ®Google Scholar
• SannaVSechiMNanoparticle therapeutics for prostate cancer treatmentMaturitas2012731273222341739
   PubMed Web of Science ®Google Scholar
• SiddiquiIAAdhamiVMChamcheuJCMukhtarHImpact of nanotechnology in cancer: emphasis on nanochemopreventionInt J Nanomedicine2012759160522346353
   PubMed Web of Science ®Google Scholar
• SannaVSiddiquiIASechiMMukhtarHNanoformulation of natural products for prevention and therapy of prostate cancerCancer Lett2013334114215123201598
   PubMedGoogle Scholar
• SurhYJCancer Chemoprevention with dietary phytochemicalsNat Rev Cancer200331076878014570043
   PubMed Web of Science ®Google Scholar
• ReddyLOdhavBBhoolaKDNatural products for cancer prevention: a global perspectivePharmacol Ther200399111312804695
   PubMed Web of Science ®Google Scholar
• BettuzziSBrausiMRizziFCastagnettiGPeracchiaGCortiAChemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle studyCancer Res20066621234124016424063
   PubMed Web of Science ®Google Scholar
• KurahashiNSasazukiSIwasakiMInoueMTsuganeSJPHC Study GroupGreen tea consumption and prostate cancer risk in japanese men: a prospective studyAm J Epidemiol20081671717717906295
   PubMed Web of Science ®Google Scholar
• KhanNAdhamiVMMukhtarHReview: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studiesNutr Cancer200961683684120155624
   PubMed Web of Science ®Google Scholar
• MukhtarHChemoprevention: Making it a success story for controlling human cancerCancer Lett2012326212312722634499
   PubMedGoogle Scholar
• MillimounoFMDongJYangLLiJLiXTargeting apoptosis pathways in cancer and perspectives with natural compounds from mother natureCancer Prev Res (Phila)2014711108110725161295
   PubMed Web of Science ®Google Scholar
• ByrneJDBetancourtTBrannon-PeppasLActive targeting schemes for nanoparticle systems in cancer therapeuticsAdv Drug Deliv Rev200860151615162618840489
   PubMed Web of Science ®Google Scholar
• AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
   PubMed Web of Science ®Google Scholar
• SannaVPalaNSechiMTargeted therapy using nanotechnology: focus on cancerInt J Nanomedicine2014946748324531078
   PubMed Web of Science ®Google Scholar
• HuangYZhouDHangTPreparation, characterization, and assessment of the antiglioma effects of liposomal celastrolAnticancer Drugs201223551552422343423
   PubMed Web of Science ®Google Scholar
• ElzeinTNasser-EddineMDelaiteCBistacSDumasPFTIR study of polycaprolactone chain organization at interfacesJ Colloid Interface Sci2004273238138715082371
   PubMed Web of Science ®Google Scholar
• KisterGCassanasGBergounhonMHoarauDVertMStructural characterization and hydrolytic degradation of solid copolymers of d,l-lactide-co-ε-caprolactone by Raman spectroscopyPolymer2000413925932
   Google Scholar
• ErmeydanMACabaneEHassPKoetzJBurgertIFully biodegradable modification of wood for improvement of dimensional stability and water absorption properties by poly(ε-caprolactone) grafting into the cell wallsGreen Chem20141633133321
   Web of Science ®Google Scholar
• ZhangXZhangTZhouXEnhancement of oral bioavailability of tripterine through lipid nanospheres: preparation, characterization, and absorption evaluationJ Pharm Sci201410361711171924700417
   PubMed Web of Science ®Google Scholar
• FonsecaCSimoesSGasparRPaclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activityJ Control Release200283227328612363453
   PubMed Web of Science ®Google Scholar
• PanyamJLabhasetwarVDynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cellsPharm Res200320221222012636159
   PubMed Web of Science ®Google Scholar
• SiddiquiIASannaVAhmadNSechiMMukhtarHResveratrol nanoformulation for cancer prevention and therapyAnn N Y Acad Sci201513481203126109073
   PubMedGoogle Scholar
• ZhouYXHuangYLAntiangiogenic effect of celastrol on the growth of human glioma: an in vitro and in vivo studyChin Med J (Engl)2009122141666167319719969
   PubMed Web of Science ®Google Scholar
• PangXYiZZhangJCelastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathwayCancer Res20107051951195920160026
   PubMed Web of Science ®Google Scholar
• KhanNAfaqFMukhtarHCancer chemoprevention through dietary antioxidants: progress and promiseAntioxid Redox Signal200810347551018154485
   PubMed Web of Science ®Google Scholar
• RouleauMPatelAHendzelMJKaufmannSHPoirierGGPARP inhibition: PARP1 and beyondNat Rev Cancer201010429330120200537
   PubMed Web of Science ®Google Scholar
• ShaoLZhouZCaiYCelastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancerPLoS One201383e5839123554889
   PubMedGoogle Scholar